Goldman Sachs released a research report stating that it has raised ANGELALIGN's (06699) target price from HK$78.8 to HK$81.3 using the Sum of The Parts (SOTP) valuation method, maintaining a "Buy" rating. ANGELALIGN's first-half revenue reached US$161 million, representing a 33% year-over-year increase that exceeded expectations, primarily driven by rapid overseas business expansion. The gross margin remained stable at 62.4%, unchanged from the same period last year. Despite implementing strategic price adjustments in its domestic business, the company maintained strong profitability levels, while overseas gross margin expanded to 61.2% from 58.3% in the prior year period. Management has raised its full-year case volume guidance to 490,000-500,000 cases, representing year-over-year growth of 36% to 39%.